Covid-19: Maldives approves China's Sinopharm vaccine for emergency use
The Covid-19 vaccine developed by China's Sinopharm has been approved for emergency use in the Maldives, the Maldives Food
and Drug Administration (MFDA) announced at a press conference on Monday.
The
vaccine made by China National Pharmaceutical Group (Sinopharm) will be given
to people aged between 18 and 60, local media reported, citing an official at
the MFDA. The MFDA also announced that the vaccine made by Pfizer has also been
approved for emergency use, the Xinhua news agency reported.
The
Covishield vaccine based on a formula by AstraZeneca and Oxford University and
manufactured by the Serum Institute of India was approved for emergency use in
late January.
The
government of Maldives has been vaccinating its population against the pandemic
since February 1, prioritising frontline health workers and other high-risk
groups. Vaccinations are available free of charge to residents over the age of
18, including undocumented immigrants. Read More
Comments
Post a Comment